- Home
- BGM vs CLNN Comparison
BGM vs CLNN Comparison
Compare BGM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- CLNN
- Stock Information
- Founded
- BGM 2019
- CLNN 2012
- Country
- BGM China
- CLNN United States
- Employees
- BGM N/A
- CLNN N/A
- Industry
- BGM
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- BGM
- CLNN Health Care
- Exchange
- BGM NYSE
- CLNN Nasdaq
- Market Cap
- BGM 50.6M
- CLNN 43.0M
- IPO Year
- BGM 2021
- CLNN N/A
- Fundamental
- Price
- BGM $8.75
- CLNN $4.34
- Analyst Decision
- BGM
- CLNN Strong Buy
- Analyst Count
- BGM 0
- CLNN 4
- Target Price
- BGM N/A
- CLNN $55.25
- AVG Volume (30 Days)
- BGM 46.0K
- CLNN 121.3K
- Earning Date
- BGM 02-13-2025
- CLNN 11-13-2024
- Dividend Yield
- BGM N/A
- CLNN N/A
- EPS Growth
- BGM N/A
- CLNN N/A
- EPS
- BGM N/A
- CLNN N/A
- Revenue
- BGM $29,870,461.00
- CLNN $421,000.00
- Revenue This Year
- BGM N/A
- CLNN N/A
- Revenue Next Year
- BGM N/A
- CLNN N/A
- P/E Ratio
- BGM N/A
- CLNN N/A
- Revenue Growth
- BGM N/A
- CLNN N/A
- 52 Week Low
- BGM $1.78
- CLNN $3.82
- 52 Week High
- BGM $11.67
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- BGM 56.83
- CLNN 44.40
- Support Level
- BGM $8.15
- CLNN $4.22
- Resistance Level
- BGM $8.80
- CLNN $5.47
- Average True Range (ATR)
- BGM 0.79
- CLNN 0.45
- MACD
- BGM -0.01
- CLNN 0.06
- Stochastic Oscillator
- BGM 17.82
- CLNN 30.57
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).